CPA is a resource and support network for professional pharmacy associations and individual pharmacists, empowering Pharmacists to improve health and well being throughout the Commonwealth.
BSAC is a professional society and global educator, connecting scientific researchers, medical communities and the wider public to stop the growing threat of drug-resistant infections.
This new agreement will increase collaboration between the two organisations by leveraging the organizations’ different areas of expertise:
“As one of the world’s leading infectious disease societies, we are delighted to collaborate with the CPA,” said Tracey Guise, BSAC Chief Executive Officer. “This MOU signals the enhancement of a partnership that will allow us develop and implement an exciting programme of work that will seek to put forward innovative solutions to the challenge of antibiotic resistance, helping to reduce infection and drive up healthcare standards around the world.”
“The CPA welcomes the development of this MOU, which aims to leverage the strengths of both organisations and collectively create more resources and opportunities for Pharmacists and their colleagues across the Commonwealth to support the development of effective models of AMS and help to create a joined up approach to tackling AMR,” said Victoria Rutter, CPA Chief Executive Officer.
Established in 1969, the Commonwealth Pharmacists Association (CPA) is the professional body for national pharmacy associations in Commonwealth countries. The CPA advances health, promotes wellbeing, and improves education for the benefit of the people of the Commonwealth, which encompass some of the world’s poorest nations. The CPA supports the development of safe and effective systems of medicines management, healthier lifestyles, and the reduction of health inequalities. This is achieved through building strong collaborative networks, partnering with member organizations to improve the quality of pharmacy practice and creating platforms for the dissemination of knowledge about pharmaceutical sciences and professional practice.
The British Society for Antimicrobial Chemotherapy (BSAC) is an inter-professional organisation and global educator, with members in 135 countries around the world. Founded in 1971, the Society has half a century of experience and achievement in antibiotic education, research, and leadership. Dedicated to saving lives through the appropriate development and use of antibiotics, it supports a large global network via events, online education, professional guidelines and its own international journals, the Journal of Antimicrobial Chemotherapy (JAC) and its sister publication, JAC-AMR.